KERALA AYURVEDA LTD.

Kerala Ayurveda Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure will be effective from Tuesday, June 30, 2026, and will remain in effect for 48 hours after the announcement of the unaudited financial results for the quarter ending June 30, 2026. The company will separately announce the date of the Board of Directors' meeting to approve these results. In line with SEBI regulations, the PAN of designated persons and their relatives will be frozen for trading during this period.

Kerala Ayurveda Ltd announced the resignation of Mr. Samir Dhawan, an Independent Director, effective June 09, 2026. The resignation is attributed to his other professional commitments requiring increased time and attention, preventing him from dedicating the necessary time to his directorial responsibilities. Mr. Dhawan confirmed there are no other material reasons for his departure. The company has complied with SEBI Listing Regulations by providing the resignation letter and necessary disclosures.

Kerala Ayurveda Ltd has informed the stock exchanges that under Regulation 30(5) of SEBI Listing Regulations, specific Key Managerial Personnels (KMPs) are authorized to determine the materiality of events and make disclosures. The authorized personnel include the Whole-time Director, CEO, CFO, and Company Secretary. This measure ensures compliance with disclosure norms and streamlines the process of informing the stock exchanges about significant company information.

Kerala Ayurveda Limited announced the appointment of Mr. Binu Thomas as the new Company Secretary and Compliance Officer, effective June 9, 2026. Mr. Thomas brings over 10 years of post-qualification experience in secretarial and compliance functions for listed entities. He is a Fellow Member of the Institute of Company Secretaries of India and holds an MBA. His prior role was with Harrisons Malayalam Limited. This appointment was approved by the Board of Directors.

Kerala Ayurveda Ltd (KAL) reported a 22% revenue growth in FY26, reaching ₹145.4 Cr, driven by its India E-Product business. The standalone business crossed ₹100 Cr in revenue for the first time. KAL aims for a 50% operating revenue growth in FY27, targeting ₹200 Cr in total revenue and operating break-even by January 2027, despite increased marketing investments. The company is consolidating its Ayurvedagram resort by acquiring the remaining 26% stake. FY26 EBITDA margin stood at -2.4%, improved by topline growth and forex gains.

Kerala Ayurveda Ltd's Board of Directors approved the audited standalone and consolidated financial results for the year ended March 31, 2026, during a meeting held on May 25, 2026. The results, accompanied by an audit report with an unmodified opinion from G. Joseph & Associates, are compliant with SEBI regulations. The board also appointed Alphonse Scaria as Internal Auditors and M/s. SLR & Associates as Cost Auditors for FY 2026-27.

Kerala Ayurveda Ltd has appointed Mr. Alphonse Scaria as the Internal Auditor and M/s. SLR & Associates as the Cost Auditors for the FY 2026-27. This decision was made during the Board of Directors meeting held on May 25, 2026. The board also approved the audited financial results for the quarter and year ended March 31, 2026, with an unmodified opinion from the statutory auditors, M/s. G. Joseph & Associates.

Kerala Ayurveda Ltd's board meeting on May 25, 2026, approved the audited financial results (standalone and consolidated) for the quarter and year ended March 31, 2026. G. Joseph & Associates issued an unmodified audit report. Mr. Alphonse Scaria was appointed as Internal Auditors for FY 2026-27, and M/s. SLR & Associates as Cost Auditors for FY 2026-27.

Kerala Ayurveda Ltd has announced that a meeting of the Board of Directors is scheduled for May 25, 2026, to consider and approve the audited financial results (standalone and consolidated) for the quarter and year ended March 31, 2026. The trading window for dealing in the company's securities is closed from March 31, 2026, and will reopen 48 hours after the results are made public, as per SEBI regulations.

Kerala Ayurveda Ltd announced that BSE Limited rejected its waiver application for a ₹5,31,000 fine (including GST) on April 16, 2026. The fine, imposed on August 29, 2025, was due to non-compliance with Board composition requirements under Regulation 17(1) of the Listing Regulations for the period from October 1, 2024, to June 30, 2025. The company had already remitted the fine amount to BSE under protest on March 10, 2026. The company states there is no material financial implication beyond the fine amount.